Pharmaceutical applications of hot-melt extrusion: Part I

Drug Development and Industrial Pharmacy

Volumn 33, Issue 9, 2007, Pages 909-926

  Crowley, Michael M ^a   Zhang, Feng ^a   Repka, Michael A ^b   Thumma, Sridhar ^b   Upadhye, Sampada B ^b   Battu, Sunil Kumar ^b   McGinity, James W ^c   Martin, Charles ^d  

^a PharmaForm LLC   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^d American Leistritz Extruder Corp   (United States)

Author keywords

Bioavailability; Drug delivery systems; Extruder; Immediate release; Melt extrusion; Solid dispersion; Solid molecular dispersion; Sustained release; Thermal processing

Indexed keywords

CALCIUM PHOSPHATE DIBASIC; CARBOMER; CELLABURATE; CELLACEFATE; CHITOSAN; CITRIC ACID; DRUG CARRIER; ETHYL CELLULOSE; ETHYLENE VINYL ACETATE COPOLYMER; EUDRAGIT; EVATANE; GELUCIRE; GLYCEROL PALMITOSTEARATE; HYDROXYPROPYLCELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE ACETATE SUCCINATE; IMWITOR; ISOMALT; LUNACERA; MACROGOL; MALTODEXTRIN; METHYLCELLULOSE; MICROCRYSTALLINE CELLULOSE; MICROCRYSTALLINE WAX; NOVEON; OBIPEKTIN; PARACERA; PECTIN; PLASTICIZER; POLYCARBOPHIL; POLYETHYLENE; POLYGLACTIN; POLYOX; POLYVINYL ACETATE; POLYVINYL ALCOHOL; POVIDONE; SEA CURE; SODIUM CHLORIDE; STARCH GLYCOLATE SODIUM; STEROTEK; STEROTEX; SUCROESTER; UNCLASSIFIED DRUG; UNINDEXED DRUG;

CONTROLLED RELEASE FORMULATION; DISPERSION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG IMPLANT; DRUG MANUFACTURE; DRUG MIXTURE; DRUG STABILITY; EQUIPMENT; HOT MELT EXTRUSION; PELLET EXTRUSION; PHYSICAL CHEMISTRY; PROCESS TECHNOLOGY; REVIEW; TABLET FORMULATION;

CHEMISTRY, PHYSICAL; DELAYED-ACTION PREPARATIONS; DOSAGE FORMS; DRUG CARRIERS; DRUG COMPOUNDING; DRUG INDUSTRY; EXCIPIENTS; HEAT; TECHNOLOGY, PHARMACEUTICAL;

EID: 34648812679     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040701498759     Document Type: Review

References (112)

1. Aharoni, S. M. (1998). Increased glass transition temperature in motionally constrained semicrystalline polymers. Polymers For Advanced Technologies, 9(3), 169-201.
2. Aitken-Nichol, C., Zhang, F., & McGinity, J. W. (1996). Hot melt extrusion of acrylic films. Pharm. Res., 13(5), 804-808.
3. Arwidsson, H., Hjelstuen, O., Ingason, D., & Graffner, C. (1991). Properties of ethyl cellulose films for extended release. Part 2. Influence of plasticizer content and coalescence conditions when using aqueous dispersions. Acta Pharm. Nordica, 3, 65-70.
4. Bhardwaj, R., & Blanchard, J. (1997). In vitro evaluation of poly(D,L-lactide-co-glycolide) polymer-based implants containing the alpha-melanocyte stimulating hormone analog, melanotan-I. J. Control. Release, 45(1), 49-55.
5. Bhardwaj, R., & Blanchard, J. (1998). In vitro characterization and in vivo release profile of a poly(D,L-lactide-co-glycolide)-based implant delivery system for the alpha-msh analog, melanotan-I. Int. J. Pharm., 170(1), 109-117.
6. Breitenbach, J. (2002). Melt Extrusion: From Process To Drug Delivery Technology. European Journal Of Pharmaceutics And Biopharmaceutics, 54, 107-117.
7. Breitenbach, J., & Magerlein, M. (2003). Melt extruded molecular dispersions. In I. Ghebre-Sellassie & C. Martin (Eds.), Pharmaceutical Extrusion Technology (Vol. 133) New York: Marcel Dekker Inc.
8. Brittain, H. G. (1995). Physical characterization of pharmaceutical solids (Vol. 70). New York: Marcel Dekker Inc.
9. Bruce L. D., N. H. S., Malick, A. W., Infeld, M H., & McGinity, J. W. (2005). Properties of hot-melt extruded tablet formulations for the colonic delivery of 5-aminosalicylic acid. Eur. J. Pharm. Biopharm. 59(1), 85-97.
10. Burns, S. J., Higginbottom, S., Corness, D., Hay, G., & Barnwell, S. G. (1994). Study of enteric-coated liquid-filled hard gelatin capsules with biphasic release characteristics. Int. J. Pharm., 110, 291-296.
11. Chang, B. L., Nuessle, N. O., & Haney, W. G. (1975). Characterization of hydrogen bonding between selected barbiturates and polyethylene glycol 4000 By Ir Spectral Analysis. J. Pharmaceut. Sci., 64, 1787-1797.
12. Chiou, W. L., & Reigelman, S. (1971). Pharmaceutical applications of solid dispersion systems. J. Pharmaceut. Sci., 60, 1281-1302.
13. Chokshi, R., & Zia, H. (2004). Hot-melt extrusion technique: A review. Iranian J. Pharm. Res., 3, 3-16.
14. Conors, K. A., Amidon, G. L., & Stella, V. J. (1986). Chemical stability of pharmaceuticals (2nd Edition Ed.). New York: Wiley-Interscience.
15. Crowley, M. M., Fredersdorf, A., Schroeder, B., Ucera, S., Prodduturi, S., Repka, M. A. et al. (2004a). The influence of guaifenesin and ketoprofen on the properties of hot-melt extruded polyethylene oxide films Eur. J. Pharm. Sci., 22(5), 409-418.
16. Crowley, M. M., Schroeder, B., Fredersdorf, A., Obara, S., Talarico, M., Kucera, S. et al. (2004b). Physicochemical properties and mechanism of drug release from ethyl cellulose matrix tablets prepared by direct compression and hotmelt extrusion. Int. J. Pharm., 271(1-2), 77-84.
17. Crowley, M. M., Zhang, F., Koleng, J. J., & McGinity, J. W. (2002). Stability of polyethylene oxide in matrix tablets prepared by hot-melt extrusion. Biomaterials, 23(21), 4241-4248.
18. Cuff, G., & Raouf, F. (1998). A preliminary evaluation of injection molding as a technology to produce tablets. Pharmaceut. Tech., 22, 96-106.
19. De Brabander, C., Van Den Mooter, G., Vervaet, C., & Remon, J. P. (2002). Characterization of ibuprofen as a nontraditional plasticizer of ethyl cellulose. J. Pharm. Sci., 91(7), 1678-1685.
20. De Brabander, C., Vervaet, C., Fiermans, L., & Remon, J. P. (2000). Matrix mini-tablets based on starch/microcrystalline wax mixtures. Int. J. Pharm., 199(2), 195-203.
21. Delahaye, N., Duclos, R., Saiter, J. M., & Varnier, S. (1997). Characterization of solid dispersion phase transition using a new optical thermal analyzer. Drug Dev. Ind. Pharm., 23, 293-303.
22. Doetsch, W. (2003). Material handling and feeder technology. In I. Ghebre-Sellassie & C. Martin (Eds.), Pharmaceutical extrusion technology (Volume 133, pp. 111-134). New York: Marcel Dekker.
23. Dreiblatt, A. (2003). Process design. In I. Ghebre-Sellassie (Ed.), Pharmaceutical extrusion technology (Volume 133, pp. 153-169). New York: Marcel Dekker, Inc.
24. El-Egakey, M. A., Soliva, M., & Speiser, P. (1971). Hot extruded dosage forms Part I: Technology and dissolution kinetics of polymeric matrices. Pharm. Acta Helv., 46, 31-52.
25. Follonier, N., Doelker, E., & Cole, E. T. (1994). Evaluation of hot-melt extrusion as a new technique for the production of polymer-based pellets for sustained release capsules containing high loadings of freely soluble drugs. Drug Dev. Ind. Pharm., 20(8), 1323-1339.
26. Follonier, N., Doelker, E., & Cole, E. T. (1995). Various ways of modulating the release of diltiazem hydrochloride from hot-melt extruded sustained release pellets prepared using polymeric materials. J. Contr. Release, 36(3), 243-250.
27. Forster, A., Hempenstall, J., & Rades, T. (2001a). Characterization of glass solutions of poorly water-soluble drugs produced by melt extrusion with hydrophilic amorphous polymers. J. Pharm. Pharmacol., 53(3), 303-315.
28. Forster, A., Hempenstall, J., Tucker, I., & Rades, T. (2001b). The potential of small-scale fusion experiments and the gordon-taylor equation to predict the suitability of drug/polymer blends for melt extrusion. Drug Dev. Ind. Pharm., 27(6), 549-560.
29. Forster, A., Hempenstall, J., Tucker, I., & Rades, T. (2001c). Selection of excipients for melt extrusion with two poorly water-soluble drugs by solubility parameter calculation and thermal analysis. Int. J. Pharm., 226, 147-161.
30. Fried, J. R. (1995). Polymer science and technology. N.J: Ptr Prentice Hall: Englewood Cliffs.
31. Fukuda, M., Peppas, N. A., & McGinity, J. W. (2006a). Floating hot-melt extruded tablets for gastroretentive controlled drug release system. J. Of Cont. Rel., 115(2), 121-129.
32. Fukuda, M., Peppas, N. A., & McGinity, J. W. (2006b). Properties of sustained release hot-melt extruded tablets containing chitosan and xanthan gum. Int. J. Pharm., 31, 90-100.
33. Ghebre-Sellassie, I., & Martin, C. (2003). Future trends. In I. Ghebre-Sellasie & C. Martin (Eds.), Pharmaceutical extrusion technology. Drugs and the pharmaceutical sciences (Volume 133, pp. 383-392). New York: Marcel Dekker.
34. Ghebremeskel, N. A., Vemavarapu, C., & Lodaya, M. (2006). Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: Stability testing of selected solid dispersions. Pharm. Res, 23(8), 1928-1936.
35. Griff, A. L. (1968). Plastics extrusion technology (2nd Edition Ed.). Malabar: Robert E. Krieger Publishing Company.
36. Grunhagen, H. H., & Muller, O. (1995). Melt extrusion technology. Pharm. Manuf. Int., 166-170.
37. Hamaura, T., & Newton, J. M. (1999). Interaction between water and poly(vinylpyrrolidone) containing polyethylene glycol. J. Pharm. Sci., 88(11), 1228-1233.
38. Henrist, D., Lefebvre, R. A., & Remon, J. P. (1999). Bioavailability of starch based hot stage extrusion formulations. Int. J. Pharm., 187(2), 185-191.
39. Henrist, D., & Remon, J. P. (1999a). Influence of the formulation composition on the in vitro characteristics of hot stage extrudates. Int. J. Pharm, 188(1), 111-119.
40. Henrist, D., & Remon, J. P. (1999b). Influence of the process parameters on the characteristics of starch based hot stage extrudates. Int. J. Pharm., 189(1), 7-17.
41. Hulsmann, S., & Backensfeld, T. (2000). World 0057853.
42. Hulsmann, S., Backensfeld, T., & Bodmeier, R. (2001). Stability of extruded 17 ss-estradiol solid dispersions. Pharm. Dev. Technol, 6(2), 223-229.
43. Hulsmann, S., Backensfeld, T., Keitel, S., & Bodmeier, R. (2000). Melt extrusion - an alternative method for enhancing the dissolution rate of 17-estradiol hemihydrate. Eur. J. Pharm. Biopharm., 49, 237-242.
44. Kaufman, H. S., & Falcetta, J. J. (1977). Introduction to polymer science and technology: an spe textbook (1st Ed.). New York: John Wiley & Son.
45. Keleb, E. I., Vermeire, A., Vervaet, C., & Remon, J. P. (2001). Cold extrusion as a continuous single-step granulation and tabletting process. Eur. J. Pharm. Biopharm., 52(3), 359-368.
46. Kerns, E. H. (2001). High throughput physicochemical profiling for drug discovery. J. Pharm. Sci., 90(11), 1838-1858.
47. Kidokoro, M., Shah, N. H., Malick, A. W., Infeld, M. H., & McGinity, J. W. (2001). Properties of tablets containing granulations of ibuprofen and an acrylic copolymer prepared by thermal processes. Pharmaceut. Dev. Tech., 6(2), 263-275.
48. Kinoshita, M., Baba, K., Nagayasu, A., Yamabe, K., Shimooka, T., Takeichi, Y. et al. (2002). improvement of solubility and oral bioavailability of a poorly water-soluble drug, TAS-301, by its melt-adsorption on a porous calcium silicate. J. Pharm. Sci., 91(2), 362-370.
49. Koleng, J. J., & McGinity, J. W. (1997). Preparation and evaluation of rapid-release granules using a novel hot-melt extrusion technique. Paper Presented At The 16th Pharmaceutical Technology Conference, Athens.
50. Lindberg, N. O., Tufvesson, C., Holm, P., & Olbjer, L. (1988). Extrusion of an effervescent granulation with a twin screw extruder, Baker Perkins Mpf 50 D. influence on intragranular porosity and liquid saturation. Drug Dev. Ind. Pharm., 14(13), 1791-1798.
51. Lindberg, N. O., Tufvesson, C., & Olbjer, L. (1987). Extrusion of an effervescent granulation with a twin screw extruder, Baker Perkins Mpf 50 D. Drug Dev. Ind. Pharm., 13, 1891-1913.
52. Liu, J., Zhang, F., & McGinity, J. W. (2001). Properties of lipophilic matrix tablets containing phenylpropanolamine hydrochloride prepared by hot-melt extrusion. Eur. J. Pharm. Biopharm., 52, 181-190.
53. Luker, K. (2003). Single-screw extrusion and screw design. In I. Ghebre-Sellassie & C. Martin (Eds.), Pharmaceutical extrusion technology. Drugs and the pharmaceutical sciences (Volume 133, pp. 39-68). Newyork: Marcel Dekker.
54. Lyons. J. G., D. D. M., Kennedy. J. E., Geever. L. M., O'sullivan. P., & Higginbotham. C. L. (2006). The use of agar as a novel filler for monolithic matrices produced using hot melt extrusion. Eur. J. Of Pharm. And Biopharm;, 64(1), 75-81.
55. Mccrum, N. G., & Buckley, C. P. (1997). Principles of polymer engineering. Oxford: Oxford University Press.
56. McGinity, J., & Zhang, F. (1997). World Patent No. 9749384.
57. McGinity, J. W., & Zhang, F. (2003). Melt-extruded controlled-release dosage forms. In I. Ghebre-Sellassie & C. Martin (Eds.), Pharmaceutical extrusion technology (Volume 133, pp. 183-208). New York: Marcel Dekker.
58. Mididoddi, P. K., Prodduturi, S., & Repka, M. A. (2006). Influence of tartaric acid on the bioadhesion and mechanical properties of hot-melt extruded hydroxypropyl cellulose films for the human nail. Drug Dev. Ind. Pharm., 32, 1059-1066.
59. Miller, D. A, M. J. T., Yang, W., Williams, R. O., & McGinity, J. W. (2006). Hot-melt extrusion for enhanced delivery of drug particles. J. Pharm. Sci., 96, 361-376.
60. Miyagawa, Y., Okabe, T., Yamaguchi, Y., & Al., E. (1996). Controlled release of diclofenac sodium from wax matrix granule. Int. J. Pharma., 138(2), 215-224.
61. Miyagawa, Y., Sato, H., Okabe, T., Nishiyama, T., Miyajima, M. A., & Sunada, H. (1999). In vivo performance of wax matrix granules prepared by a twin-screw compounding extruder. Drug Dev. Ind. Pharm., 25(4), 429-435.
62. Mollan, M. (2003). Historical overview. In I. Ghebre-Sellassie & C. Martin (Eds.), Pharmaceutical extrusion technology (Volume 133, pp. 1-18). New York, Ny: Marcel Dekker, Inc.
63. Munjal, M., Stodghill, S. P., Elsohly, M. A., & Repka, M. A. (2006). Polymeric systems for amorphous D9-tetrahydrocannabinol produced by a hot-melt method. Part I: chemical and thermal stability during processing. J. Pharm. Sci., 95(8), 1841-1853.
64. Nakamichi, K., Nakano, T., Yasuura, H., Izumi, S., & Kawashima, Y. (2002). The role of kneading paddle and the effects of screw revolution speed and water content on the preparation of solid dispersions using a twin-screw extruder. Int. J. Pharm., 241, 203-211.
65. Nakamichi, K., Yasuura, H., Fukui, H., Oka, M., & Izumi, S. (2001). Evaluation of a floating dosage form of nicardipine hydrochloride and hydroxypropylmethylcellulose acetate succinate prepared using a twin-screw extruder. Int. J. Pharm., 218(1-2), 103-112.
66. Ndindayino, F., Henrist, D., Kiekens, F., Van Den Mooter, G., Vervaet, C., & Remon, J. P. (2002a). Direct compression properties of melt-extruded isomalt. Int. J. Pharm, 235(1-2), 149-157.
67. Ndindayino, F., Vervaet, C., Van Den Mooter, G., & Remon, J. (2002b). Bioavailability of hydrochlorothiazide from isomalt-based moulded tablets. Int. J. Pharm., 246(1-2), 199-202.
68. Ndindayino, F., Vervaet, C., Van Den Mooter, G., & Remon, J. P. (2002c). Direct compression and moulding properties of co-extruded isomalt/drug mixtures. Int. J. Pharm., 235(1-2), 159-168.
69. Perdikoulias, J., & Dobbie, T. (2003). Die Design. In I. Ghebre-Sellassie & C. Martin (Eds.), Pharmaceutical extrusion technology. Drugs and the pharmaceutical sciences (Volume 133, pp. 99-110). New York: Marcel Dekkr, Inc.
70. Perissutti, B., Newton, J. M., Podczeck, F., & Rubessa, F. (2002). Preparation of extruded carbamazepine and PEG 4000 as a potential rapid release dosage form. Eur. J. Pharm. Biopharm., 53(1), 125-132.
71. Physical And Chemical Properties, Klucel®, Hydroxypropylcellulose. (1997). (pp. 2-6). Wilmington, De: Hercules Incorporated, Aqualon Division.
72. Prodduturi, S., Manek, R. V., Kolling, W. M., Stodghill, S. P., & Repka, M. A. (2005). Solid-state stability and characterization of hot-melt extruded poly(ethylene oxide) films. J. Pharm. Sci, 94(10), 2232-2245.
73. Rauwendaal, C. (1994). Polymer extrusion (3rd Ed.). Munich: Hanser Publisher.
74. Repka, M. A., Gerding, T. G., Repka, S. L., & McGinity, J. W. (1999a). Influence of plasticizers and drugs on the physical-mechanical properties of hydroxypropylcellulose films prepared by hot-melt extrusion. Drug Dev. Ind. Pharm., 25(5), 625-633.
75. Repka, M. A., Gerding, T. G., Repka, S. L., & McGinity, J. W. (1999b). Influence of plasticizers and drugs on the physical-mechanical properties of hydroxypropylcellulose films prepared by hot melt extrusion. Drug Dev. Ind. Pharm., 25(5), 625-633.
76. Repka, M. A., Gutta, K., Prodduturi, S., Munjal, M., & Stodghill, S. P. (2005). Characterization of cellulosic hot-melt extruded films containing lidocaine. Eur. J. Pharm. Biopharm., 59(1), 189-196.
77. Repka, M. A., Gutta, K., Prodduturi, S., Munjal, M., & Stodghill, S. P. (2005). Characterization of cellulosic hot-melt extruded films containing lidocaine. Eur. J. Pharm. Biopharm., 59(1), 189-196.
78. Repka, M. A., & McGinity, J. W. (2000a). Influence of vitamin E TPGS on the properties of hydrophilic films produced by hot-melt extrusion. Int. J. Pharm., 202(1-2), 63-70.
79. Repka, M. A., & McGinity, J. W. (2000b). Physical-mechanical, moisture absorption and bioadhesive properties of hydroxypropylcellulose hot-melt extruded films. Biomaterials, 21(14), 1509-1517.
80. Repka, M. A., & McGinity, J. W. (2001a). Bioadhesive properties of hydroxypropylcellulose topical films produced by hot-melt extrusion. J. Contr. Release, 70(3), 341-351.
81. Repka, M. A., & McGinity, J. W. (2001b). Influence of chlorpheniramine maleate on topical films produced by hot-melt extrusion. Pharmaceut. Dev. Tech., 6(3), 295-302.
82. Repka, M. A., & McGinity, J. W. (2001c). Influence of chlorpheniramine maleate on topical hydroxypropylcellulose films produced by hot-melt extrusion. Pharmaceut. Dev. Tech., 6(3), 297-304.
83. Repka, M. A., McGinity, J. W., Zhang, F., & Koleng, J. J. (2002a). Hot-melt extrusion technology. In J. Swarbrick & J. Boylan (Eds.), Encyclopedia of pharmaceutical technology (2nd Ed., Pp. 203-266). New York: Marcel Dekker.
84. Repka, M. A., Munjal, M., Elsohly, M. A., & Ross, S. (2006). Temperature stability and bioadhesive properties of d9-tetrahydrocannabinol incorporated hydroxypropyl cellulose polymer matrix systems. Drug Dev. Ind. Pharm., 32(1), 21-32.
85. Repka, M. A., O'haver, J., See, C. H., Gutta, K., & Munjal, M. (2002b). Nail morphology studies as assessments for onychomycosis treatment modalities. Int. J. Pharm., 245, 25-36.
86. Repka, M. A., Repka, S. L., & McGinity, J. W. (2002c). United States Patent No. 6375963 B1.
87. Repka, M. A., Repka, S. L., & McGinity, J. W. (2002d). United States Patent No. 6,375,963 B1.
88. Ringrose, B. J., & Kronfli, E. (1999). Feasibility study on the melt processing of radiation-grafted ethylene-vinyl acetate copolymer resins. Adv. Polym. Technol., 18(4), 343-350.
89. Rippie, E. G., & Johnson, J. R. (1969). Regulation of dissolution rate by pellet geometry. J. Pharmaceut. Sci., 58(4), 428-431.
90. Rothen-Weinhold, A., Oudry, N., Schwach-Abdellaoui, K., Frutiger-Hughes, S., Hughes, G. J., Jeannerat, D. et al. (2000). Formation of peptide impurities in polyester matrices during implant manufacturing. Eur. J. Pharm. Biopharm., 49(3), 253-257.
91. Sam, A. P. (1992). Controlled release contraceptive devices - A status-report. J. Control. Release, 22(1), 35-46.
92. Sato, H., & Miyagawa, Y. (1997). Dissolution mechanism of diclofenac sodium wax matrix granules. J. Pharmaceut. Sci., 86(8), 929-934.
93. Six, K., Murphy, J., Weuts, I., Craig, D. Q. M., Verreck, G., Peeters, J. et al. (2003). Identification of phase separation in solid dispersions of itraconazole and eudragit (R) E100 using microthermal analysis. Pharm. Res., 20(1), 135-138.
94. Sprockel, O. L., Sen, M., Shivanand, P., & Prapaitrakul, W. (1997). A melt extrusion process for manufacturing matrix drug delivery systems. Int. J. Pharm., 155(2), 191-199.
95. Steiner, R. (2003). Extruder design. In I. Ghebre-Sellassie & C. Martin (Eds.), Pharmaceutical extrusion technology. Drugs and the pharmaceutical sciences (Volume 133, pp. 19-38). New York: Marcel Dekker, Inc.
96. Stepto, R. F. T. (1997). Thermoplastic starch and drug delivery capsules. Polym. Int., 43(2), 155-158.
97. Stepto, R. F. T. (2000). Thermoplastic Starch. Paper Presented At The Macromol. Symp.
98. Strobl, G. (1997). The physics of polymers: Concepts for understanding their structures and behavior (2nd Ed.). Berlin: Springer.
99. Taylor, L. S., & Zografi, G. (1997). Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm. Res., 14(12), 1691-1698.
100. Thiele, W. (2003). Twin-screw extrusion and screw design. In I. Ghebre-Sellassie & C. Martin (Eds.), Pharmaceutical extrusion technology. Drugs and the pharmaceutical sciences (Volume 133, pp. 69-98). New York: Marcel Dekker.
101. Van Laarhoven, J. A. H., Kruft, M. A. B., & Vromans, H. (2002). Effect of supersaturation and crystallization phenomena on the release properties of a controlled release device based on eva copolymer. J. Control. Release, 82(2-3), 309-317.
102. Van Laarhoven, J. A. H., Kruft, M. A. B., & Vromans, H. (2002). In vitro release properties of etonogestrel and ethinyl estradiol from a contraceptive vaginal ring. Int. J. Pharm., 232(1-2), 163-173.
103. Whelan, T., & Dunning, D. (1996). The Dynisco Extrusion Processor Handbook. 1st Ed. London: London School Of Polymer Technology: .
104. Wu, C. M. J. (2003). Influence of methyl praben as a solid-state plasticizer on the physicochemical properties of eudragit RS PO hot-melt extrudates. J. Pharm. Biopharm., 56(1), 95-100.
105. Young, C. R.. D. C., Cerea, M., Farrell, T., Fegely, K. A., Rajabi Siahboomi, A., & McGinity, J. W. (2005). Physicochemical characterization and mechanisms of release of theophylline from melt-extruded dosage forms based on a methacrylic acid copolymer. Int. J. Pharm., 301(1-2), 112-120.
106. Young, C. R., Koleng, J. J., & McGinity, J. W. (2002). Production of spherical pellets by a hot-melt extrusion and spheronization process. Int. J. Pharm., 242, 87-92.
107. Zhang, F. (1999). Hot-melt extrusion as a novel technology to prepare sustained-release dosage forms. Unpublished Dissertation, The University Of Texas At Austin, Austin.
108. Zhang, F., & McGinity, J. W. (1999). Properties of sustained-release tablets prepared by hot-melt extrusion. Pharmaceut. Dev. Tech., 4(2), 241-250.
109. Zhang, F., & McGinity, J. W. (2000). Properties of hot-melt extruded theophylline tablets containing poly(vinyl acetate). Drug Dev. Ind. Pharm.26(9), 931-942.
110. Zhou, F., Vervaet, C., & Remon, J. P. (1996). Matrix pellets based on the combination of waxes, starches and maltodextrins. Int. J. Pharm., 133(1-2), 155-160.
111. Zhu, Y. S. N., Malick, A. W., Infeld, M. H., McGinity, J. W. (2006). Controlled release of a poorly water-soluble drug from hot-melt extrudates containing acrylic polymers. Drug Dev. Ind. Pharm., 32(5), 569-583.
112. Zhu, Y. C., Shah, N. H., Malick, A. W., Infeld, M. H., & McGinity, J. W. (2002). Solid-state plasticization of an acrylic polymer with chlorpheniramine maleate and triethyl citrate. Int. J. Pharm., 241(2), 301-310.